Arax Advisory Partners’s Covetrus, Inc. Common Stock CVET Stock Holding History

Arax Advisory Partners’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-43	Closed	-$1K	–	1287
2022 Q2	$1K	Hold	43	–	–	﹤0.01%	1149
2022 Q1	$1K	Hold	43	–	–	﹤0.01%	1144
2021 Q4	$1K	Buy	+43	New	+$810	﹤0.01%	1127

Other funds holding CVET

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Arax Advisory Partners's CVET Position: Q3 2022 in Review

Arax Advisory Partners sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2022, closing a stake of 43 shares — an estimated $1K sold.

Arax Advisory Partners first reported a position in CVET in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 250 funds tracked by Wall St. Rank hold CVET as of Q3 2022.

Arax Advisory Partners reported no remaining Covetrus, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Arax Advisory Partners sold 43 Covetrus, Inc. Common Stock shares in Q3 2022, an estimated $1K.
Arax Advisory Partners first reported a position in Covetrus, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
Arax Advisory Partners's Covetrus, Inc. Common Stock position peaked at $1K in Q2 2022.
250 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2022.

Based on Arax Advisory Partners's 13F filing for Q3 2022, filed 3 Nov 2022.